Literature DB >> 28370644

A pilot study to assess the validity of the DASS-21 subscales in an outpatient oncology population.

Claire E Johnson1, Kellie S Bennett2, Jade Newton1, Joseph McTigue1, Scott Taylor1, Toni Musiello1, Peter K H Lau3.   

Abstract

Entities:  

Keywords:  DASS-21; ambulatory oncology; anxiety; cancer patients; depression; factor analysis; global distress; stress

Year:  2017        PMID： 28370644     DOI： 10.1002/pon.4435

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  4 in total

1.  Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

Authors:  Janet Hardy; Alison Haywood; Gauri Gogna; Jennifer Martin; Patsy Yates; Ristan Greer; Phillip Good
Journal:  Trials       Date:  2020-07-06       Impact factor: 2.279

2.  An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.

Authors:  Phillip D Good; Ristan M Greer; Georgina E Huggett; Janet R Hardy
Journal:  J Palliat Med       Date:  2019-12-03       Impact factor: 2.947

3.  Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).

Authors:  Phillip Good; Alison Haywood; Gauri Gogna; Jennifer Martin; Patsy Yates; Ristan Greer; Janet Hardy
Journal:  BMC Palliat Care       Date:  2019-12-06       Impact factor: 3.234

4.  Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma.

Authors:  Jake R Thompson; Andrea L Smith; Serigne N Lo; Nadine A Kasparian; Robyn Pm Saw; Mbathio Dieng; Linda Seaman; Linda K Martin; Pascale Guitera; Donna Milne; Helen Schmid; Anne E Cust; Iris Bartula
Journal:  BMJ Open       Date:  2022-03-03       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.